Works matching IS 21623619 AND DT 2025 AND VI 14 AND IP 1

Results: 88
    1
    2
    3
    4
    5
    6
    7
    8

    Correction: Lysin (K)-specific demethylase 1 inhibition enhances proteasome inhibitor response and overcomes drug resistance in multiple myeloma.

    Published in:
    2025
    By:
    • Bandini, Cecilia;
    • Mereu, Elisabetta;
    • Paradzik, Tina;
    • Labrador, Maria;
    • Maccagno, Monica;
    • Cumerlato, Michela;
    • Oreglia, Federico;
    • Prever, Lorenzo;
    • Manicardi, Veronica;
    • Taiana, Elisa;
    • Ronchetti, Domenica;
    • D'Agostino, Mattia;
    • Gay, Francesca;
    • Larocca, Alessandra;
    • Besse, Lenka;
    • Merlo, Giorgio Roberto;
    • Hirsch, Emilio;
    • Ciarrocchi, Alessia;
    • Inghirami, Giorgio;
    • Neri, Antonino
    Publication type:
    Correction Notice
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survival.

    Published in:
    Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00623-w
    By:
    • Gile, Jennifer J.;
    • Mondello, Patrizia;
    • Wang, Zixing;
    • Li, Ying;
    • Bansal, Radhika;
    • Gandhi, Sangeetha;
    • Zhang, Henan;
    • Babadi, Elham;
    • Martinez, Kodi;
    • McCoy, Gabrielle;
    • Shao, Zuoyi;
    • Regan, Kevin;
    • Hathcock, Matthew A.;
    • Wang, Panwen;
    • Wang, Junwen;
    • Al Saleh, Abdullah S.;
    • Ruan, Gordon;
    • Ansell, Stephen M.;
    • Bennani, N. Nora;
    • Johnston, Patrick B.
    Publication type:
    Article
    28

    Hypomethylating agents plus venetoclax for high-risk MDS and CMML as bridge therapy to transplant: a GESMD study.

    Published in:
    Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00652-5
    By:
    • Zugasti, Ines;
    • Lopez-Guerra, Monica;
    • Castaño-Díez, Sandra;
    • Esteban, Daniel;
    • Avendaño, Alejandro;
    • Pomares, Helena;
    • Perez, Ana;
    • García-Ávila, Sara;
    • Conejo, Irene Padilla;
    • de la Fuente Montes, Cristina;
    • Martínez-Roca, Alexandra;
    • Merchán, Beatriz;
    • Jiménez-Vicente, Carlos;
    • Guijarro, Francesca;
    • Álamo, Jose Ramón;
    • Cortes-Bullich, Albert;
    • Torrecillas, Victor;
    • Mont, Lucia;
    • Carcelero, Esther;
    • Riu, Gisela
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    The clinical landscape of CAR NK cells.

    Published in:
    Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00633-8
    By:
    • Jørgensen, Lasse Vedel;
    • Christensen, Emil Birch;
    • Barnkob, Mike Bogetofte;
    • Barington, Torben
    Publication type:
    Article
    44
    45
    46

    Siltuximab for the treatment of early complications after chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia in children, adolescents, and young adults.

    Published in:
    Experimental Hematology & Oncology, 2025, v. 14, n. 1, p. 1, doi. 10.1186/s40164-025-00638-3
    By:
    • Galán-Gómez, Víctor;
    • González-Martínez, Berta;
    • Alonso-Saladrigues, Anna;
    • Rives, Susana;
    • Herrero, Blanca;
    • Kwon, Mi;
    • Sánchez-Pina, Jose;
    • Minguillón, Jordi;
    • Martínez-Romera, Isabel;
    • Mirones Aguilar, Isabel;
    • Mestre-Durán, Carmen;
    • Casado, Gema;
    • Sánchez-Martín, María;
    • Echecopar, Carlos;
    • González-Pérez, Carlos;
    • León-Triana, Odelaisy;
    • Aguirre-Portolés, Cristina;
    • Molinos-Quintana, Águeda;
    • Barba, Pere;
    • Balsalobre, Pascual
    Publication type:
    Article
    47
    48
    49
    50